YahooOctober 19, 2026 at 7:02 PM NY8 Days Ago
CytoDyn Highlights Early CLOVER Data, Names Robert Hoffman CEO
CytoDyn (OTCMKTS:CYDY) provided an update on its Phase II CLOVER study of leronlimab in metastatic colorectal cancer, highlighting early circulating tumor DNA, or ctDNA, data, preliminary clinical observations and plans for additional studies. The company also announced that CFO Robert Hoffman will
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
